The FINANCIAL -- Vaccines are a critical part of slowing, and eventually stopping, the spread of COVID-19, and Kaiser Permanente…
The FINANCIAL -- "Twelve months ago, the world came together to support COVAX, a multilateral initiative aimed at guaranteeing global access…
Of the 203 million people who have received at least one dose of a covid-19 vaccine, more than 9 million…
The FINANCIAL -- Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success…
The FINANCIAL -- Study of 6.2 million patients by Kaiser Permanente and CDC researchers will continue for 2 years. Federal and…
The FINANCIAL -- Researchers from the University of Oxford have today announced the results of a study into thrombocytopenia (a…
In a recent webinar presented by the Kennedy School’s Shorenstein Center on Media, Politics and Public Policy, Matthew Baum and…
The FINANCIAL -- According to Pfizer, COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on…
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant of concern dominant…
More than half a year has passed since the first vaccine for COVID-19 was given emergency authorization, and almost half…
The FINANCIAL -- A new study led by the University of Oxford has found that previous infection, whether symptomatic or…
The FINANCIAL -- The CDC says that fully vaccinated individuals can resume many day-to-day activities without a mask, leading many…
The FINANCIAL -- Ziad Mallat has a bold ambition: he wants to help create a world free from heart attacks…
The FINANCIAL -- People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but…
The FINANCIAL -- Global pharmaceutical company Janssen will begin clinical trials of its potential vaccine in the UK from today…